Storys aus Switzerland

Sophia Genetics

SOPHiA GENETICS Raises $110 Million in Oversubscribed New Funding Round

Lausanne, Switzerland and Boston (ots/PRNewswire) - Supporting the Company's Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine - SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader - Company ...

Debiopharm International SA

DEBIOPHARM HONORED AS A 2020 SWISS BIOTECH SUCCESS STORY WINNER FOR OUTSTANDING ACHIEVEMENTS OVER 40 YEARS

Lausanne, Switzerland (ots) - Debiopharm, (www.debiopharm.com), a Swiss-based biopharmaceutical company today announced being one of the recipients of the 2020 Swiss Biotech Success Story Award for exceptional achievements in the biotech industry. Every year, the Swiss Biotech Association awards companies or ...

Debiopharm International SA

DEBIOPHARM TO PRESENT LATE BREAKING HEAD & NECK CANCER ABSTRACT AT THE 2020 EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS

Lausanne, Switzerland (ots) - Debiopharm announces the presentation of the 3-year phase II follow-up data along with 2 posters for xevinapant (antagonist of IAP -Inhibitor of Apoptosis Proteins) and WEE1 inhibitor Debio 0123 Debiopharm, ...

Debiopharm International SA

DEBIOPHARM'S IAP ANTAGONIST SIGNIFICANTLY IMPROVES OVERALL SURVIVAL OF HIGH-RISK HEAD & NECK CANCER PATIENTS

Lausanne, Switzerland (ots) - Promising overall survival outcomes at 3-years for high-risk, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) patients observed with Debio 1143 + CRT Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, today announced the release of ...

Ascensia Diabetes Care; PHC Holdings Corporation

PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics

Tokyo and Basel, Switzerland (ots/PRNewswire) - PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose ...

Versameb AG

Versameb raises CHF 6 million and strengthens team to advance its VERSagile technology platform towards clinical trials

Basel, Switzerland (ots) - Versameb AG, a biopharmaceutical company developing innovative ribonucleic acid (RNA) therapeutics, announced today the closing of a CHF 6 million seed financing round. Versameb further strengthens its team by the appointment of Dr. Klaas P. Zuideveld as Chief Development Officer effective ...

Debiopharm International SA

NUCLEAI SECURED $6.5M SERIES-A INITIAL CLOSING LED BY DEBIOPHARM TO ADVANCE AI-POWERED PRECISION ONCOLOGY PLATFORM

Tel Aviv, Israel, Lausanne, Switzerland (ots) - - Nucleai, a computational biology company providing an AI-powered precision oncology platform for research and treatment decisions, secured $6.5M Series A initial closing. - Debiopharm's strategic corporate venture capital fund led the round joined by existing ...

Carag

Carag Receives U.S. FDA IDE Approval to Conduct Clinical Study of First Transcatheter Septal Occluder With Bioresorbable, Metal-free Framework

Baar, Switzerland (ots/PRNewswire) - The U.S. trial for CE-marked CBSO is designed to enroll up to 250 patients in a staged study approach CARAG AG, a privately-held Swiss medical device development company, today announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) ...

Galderma

Galderma Global Research Reveals Struggles of People With Rosacea and Psoriasis of the Face Experiencing a Lack of Control and Impact on Mental Wellbeing

Lausanne, Switzerland (ots/PRNewswire) - Healthcare professionals (HCPs) encouraged to investigate true impacts beyond the visible, empower patients with knowledge and aim for 'clear' (IGA 0) skin to improve outcomes A new expert-authored Galderma report (https://hosted.bmj.com/rosaceabeyondthevisible) released ...

Neovii Pharmaceuticals AG

NEOVII Partners with Tel Aviv University to Develop Novel COVID-19 Vaccine

Rapperswil, Switzerland and Tel Aviv, Israel (ots/PRNewswire) - The epitope-based vaccine will target the most vulnerable part of the viral spike protein Ramot , Tel Aviv University's technology transfer company, and Neovii , a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license ...

Neovii Pharmaceuticals AG

NEOVII to Develop a Novel Vaccine for COVID-19 in an Exclusive Partnership With Tel Aviv University

Rapperswil, Switzerland (ots/PRNewswire) - Neovii, the Swiss-based biopharmaceutical company and a member of Israeli-based Neopharm Group, has signed a research and license agreement with Tel Aviv University's (TAU) RAMOT, its technology transfer company, to work in collaboration with a team led by Professor ...

ForaCare Suisse AG

ForaCare Providing Critical Tools to Help Control COVID-19 Spread / Autonomous Temperature Measurement, Pulse Oximetry, TeleHealth System Help Medical Personnel, Businesses and Patients

Cybel'Art SA

1

2

icologram® presents its enhanced reality application " Art & Music " to enjoy at home the emotions of " live music" performances

Loylogic

The ENTERTAINER Partners With PointsPay To Offer Members the Power to Pay with Loyalty Points

Zurich, Switzerland (ots) - Global digital lifestyle brand, the ENTERTAINER and PointsPay, Loylogic's innovative loyalty e-payment platform, announce an exciting new partnership that now offers members the chance to use their loyalty program 'points' and 'miles' to purchase on the ENTERTAINER. PointsPay by Loylogic is a payment platform that, among others, provides ...

Sophia Genetics

SOPHiA GENETICS Expands Its Executive Team, Naming Lara Hashimoto Chief Business Officer

Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Lara Hashimoto has joined its Executive Team as Chief Business Officer, effective April 1st. She will be responsible for Marketing, Product Management and Business Development. Lara Hashimoto joined the healthcare industry 20 years ago holding ...

X-Technology Swiss R&D AG

2

RECORD-BREAKING PERFORMANCE LEADS THE X-BIONIC® & SWISS SKI PARTNERSHIP TO HISTORIC WIN OF THE NATIONS CUP!

APR

FDA Grants Orphan Drug Designation to APR-OD031 for the Treatment of Phenylketonuria (PKU)

Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research s.a. ("APR"), the Swiss pharma company leveraging drug delivery technologies to develop innovative products for niche and rare diseases, today announced that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for the Company's drug candidate APR-OD031 for the treatment ...

Sophia Genetics

SOPHiA GENETICS and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic

Lausanne, Switzerland, and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next-generation sequencing (NGS) assay and leveraging the SOPHiA Platform analytical capabilities, as well as delivering ...

X-Technology Swiss R&D AG

2

PUMA I X-BIONIC® PRODUCT SERIES WINS THE PRESTIGIOUS PLUS X AWARD / For Innovation, Design, Functionality, Ergonomics and High Quality

Hitachi Medical Systems Europe Holding AG

Hitachi Medical Systems Europe launches "ARIETTA 750", the new model from the ARIETTA series of diagnostic ultrasound platforms / This model inherited premium class technologies

CARAG AG

Carag First-ever Septal Occluder With Bioresorbable, Metal-free Framework Available to Patients Through New European Registry

Baar, Switzerland and Berlin (ots/PRNewswire) - First 3-year-old patient successfully implanted and discharged from hospital in Berlin CARAG AG, a Swiss privately held medical device development company, announced today the successful implantation of the first-ever transcatheter septal occluder with bioresorbable, ...

European Alliance of News Agencies (EANA)

EANA expresses concern and dismay over closure of Australian Associated Press (AAP)

Bern, Switzerland (ots) - The upcoming closure of AAP is a sad moment for Australia, for the Australian media community, for the Australian public and for the international news agency community. The European Alliance of News Agencies expresses ist concern and sadness about the recent announcement by AAP. In a general media landscape already under pressure from a flood ...

Sophia Genetics

SOPHiA GENETICS' Board of Directors Elects Troy Cox as New Chairman

Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that former Foundation Medicine CEO Troy Cox has been elected as Chairman of the Board of Directors, effective March 1, 2020. He is replacing Antoine Duchateau, who has served as chairman since 2013 and will continue as a board member. Cox joined the ...

VirtaMed AG

A revolution in laparoscopic training: KARL STORZ and VirtaMed leap beyond VR simulation